Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API

Д.К. Махкамова

6 та иш

Tashkent Institute of Postgraduate Medical Education, 51 Parkent St., Tashkent, Uzbekistan, 100009

  1. Etiopathogenesis of ocular ischemic syndrome

    Д.К. Махкамова

    Шарҳ мақолаCerebrovascular and Carotid Artery DiseasesRussian Annals of Ophthalmology20171 иқтибос
    ABI

  2. LEVEL OF MARKERS OF NEURODEGENERATION IN PATIENTS WITH OCULAR ISCHEMIC SYNDROME

    H. M. Kamilov, Munirahon Kasimova, Д.К. Махкамова

    МақолаNeurological Disorders and TreatmentsEuropean Medical Health and Pharmaceutical Journal20140 иқтибос
    ABI

  3. EVALUATING THE EFFECTIVENESS OF FRUCTOSE-1,6-DIPHOSPHATE IN TREATING OF OCULAR ISCHEMIC SYNDROME

    Д.К. Махкамова

    МақолаCerebrovascular and Carotid Artery DiseasesEuropean Medical Health and Pharmaceutical Journal20150 иқтибос
    ABI

  4. Analysis of choline alfoscerate effectiveness in chronic ocular ischemic syndrome

    Х. М. Камилов, М.С. Касимова, Д.К. Махкамова

    МақолаNeurological Disorders and TreatmentsRussian Annals of Ophthalmology20160 иқтибос
    ABI

  5. Рenetrating operations of the eyeball as triggering factor of ocular ischemic syndrome

    Д.К. Махкамова

    МақолаCerebrovascular and Carotid Artery DiseasesOphthalmology in Russia20160 иқтибос
    ABI

  6. Short-term efficacy of a monoclonal antibody fragment (brolucizumab) for treating neovascular age-related macular degeneration

    A.F. Yusupov, М.Х. Каримова, Sh.A. Djamalova +5

    МақолаRetinal Diseases and TreatmentsOftalmologicheskii Zhurnal20240 иқтибос
    ABI